Filippo Acconcia

Filippo Acconcia

Oct 14, 2017

Group 6 Copy 106
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Regulation of Spore Dormancy in Pathogenic Fungi

Tiny fungal spores and yeast forms are found in the soil, air, and water. Infection takes hold when spores break...

Can we stop the spread of breast cancer?

Cancer treatment is a challenging, complex and exhausting process for the patient, their family and medical...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Campaign Ended